Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma

Oncogene

Volumn 30, Issue 37, 2011, Pages 3907-3917

  Su, Y ^a,b,c   Wagner, E R ^b   Luo, Q ^a,b,c   Huang, J ^b,c   Chen, L ^b,c   He, B C ^b,c   Zuo, G W ^b,c   Shi, Q ^b,c   Zhang, B Q ^b,c   Zhu, G ^a,b,c   Bi, Y ^a,b,c   Luo, J ^b,c   Luo, X ^b,c   Kim, S H ^b   Shen, J ^b   Rastegar, F ^b   Huang, E ^b,d   Gao, Y ^b,e   Gao, J L ^b   Yang, K ^b,f   Wietholt, C ^b   Li, M ^a,c   Qin, J ^a,b,c   Haydon, R C ^b   He, T C ^a,b,c   Luu, H H ^b   more..

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d CHONGQING UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

^f THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

animal model; IGFBP5; metastasis; osteosarcoma; tumorigenesis

Indexed keywords

ADENOVIRUS VECTOR; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PATHOGENESIS; PRIMARY TUMOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADOLESCENT; ADULT; ANIMALS; APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHILD; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; OSTEOSARCOMA; YOUNG ADULT;

ANIMALIA; MUS MUSCULUS;

EID: 80052703371     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.97     Document Type: Article

References (39)

1. Akkiprik M, Feng Y, Wang H, Chen K, Hu L, Sahin A et al. (2008). Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer. Breast Cancer Res 10: 212.
2. Amaar YG, Thompson GR, Linkhart TA, Chen ST, Baylink DJ, Mohan S. (2002). Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem 277: 12053-12060. (Pubitemid 34952768)
3. Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A et al. (2009). Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res 69: 2443-2452.
4. Butt AJ, Dickson KA, Jambazov S, Baxter RC. (2005). Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells. Endocrinology 146: 3113-3122. (Pubitemid 41002821)
5. Butt AJ, Dickson KA, McDougall F, Baxter RC. (2003). Insulinlike growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 278: 29676-29685. (Pubitemid 36962353)
6. Cheung C, Vesey D, Cotterill A, Douglas M, Gobe G, Nicol D et al. (2005). Altered messenger RNA and protein expressions for insulinlike growth factor family members in clear cell and papillary renal cell carcinomas. Int J Urol 12: 17-28. (Pubitemid 40332998)
7. Davis AM, Bell RS, Goodwin PJ. (1994). Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12: 423-431. (Pubitemid 24056419)
8. Fuchs B, Pritchard DJ. (2002). Etiology of osteosarcoma. Clin Orthop 397: 40-52. (Pubitemid 34442014)
9. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. (1998). A simplified system for generating recombinant adenoviruses. Proc Natl Acad wSci USA 95: 2509-2514. (Pubitemid 28145972)
10. Kang Q, Song WX, Luo Q, Tang N, Luo J, Luo X et al. (2009). A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 18: 545-559.
11. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT et al. (2004). Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11: 1312-1320. (Pubitemid 39213996)
12. Kaste SC, Pratt CB, Cain AM, Jones-Wallace DJ, Rao BN. (1999). Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer 86: 1602-1608. (Pubitemid 29489798)
13. Letson GD, Muro-Cacho CA. (2001). Genetic and molecular abnormalities in tumors of the bone and soft tissues. Cancer Control 8: 239-251. (Pubitemid 32493511)
14. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J et al. (2007a). A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2: 1236-1247. (Pubitemid 46908240)
15. Luo Q, Kang Q, Si W, Jiang W, Park JK, Peng Y et al. (2004). Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 55958-55968. (Pubitemid 40066603)
16. Luo Q, Kang Q, Song WX, Luu HH, Luo X, An N et al. (2007b). Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Gene 395: 160-169. (Pubitemid 46670640)
17. Luo X, Sharff KA, Chen J, He TC, Luu HH. (2008). S100A6 expression and function in human osteosarcoma. Clin Orthop Relat Res 466: 2060-2070.
18. Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W et al. (2005a). An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22: 319-329. (Pubitemid 41374288)
19. Luu HH, Zagaja GP, Dubauskas Z, Chen SL, Smith RC, Watabe K et al. (1998). Identification of a novel metastasis-suppressor region on human chromosome 12. Cancer Res 58: 3561-3565. (Pubitemid 28376551)
20. Luu HH, Zhou L, Haydon RC, Deyrup AT, Montag AG, Huo D et al. (2005b). Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett 229: 135-148. (Pubitemid 41262550)
21. Manara MC, Landuzzi L, Nanni P, Nicoletti G, Zambelli D, Lollini PL et al. (2007). Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing's sarcoma. Clin Cancer Res 13: 1322-1330. (Pubitemid 46424074)
22. Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC, Gebhardt MC. (2004). Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop 429: 286-291. (Pubitemid 39579224)
23. Mukherjee A, Rotwein P. (2007). Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor? Growth Horm IGF Res 17: 179-185. (Pubitemid 46888315)
24. Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu BA et al. (2004). Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 32941-32949. (Pubitemid 39014754)
25. Ragland BD, Bell WC, Lopez RR, Siegal GP. (2002). Cytogenetics and molecular biology of osteosarcoma. Lab Invest 82: 365-373. (Pubitemid 34311110)
26. Rosenzweig SA. (2004). What's new in the IGF-binding proteins? Growth Horm IGF Res 14: 329-336. (Pubitemid 39185987)
27. Schedlich LJ, Le Page SL, Firth SM, Briggs LJ, Jans DA, Baxter RC. (2000). Nuclear import of insulin-like growth factor-binding protein-3 and-5 is mediated by the importin beta subunit. J Biol Chem 275: 23462-23470. (Pubitemid 30624626)
28. Schneider MR, Wolf E, Hoeflich A, Lahm H. (2002). IGF-binding protein-5: flexible player in the IGF system and effector on its own. J Endocrinol 172: 423-440. (Pubitemid 34232684)
29. Schneider MR, Zhou R, Hoeflich A, Krebs O, Schmidt J, Mohan S et al. (2001). Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells. Biochem Biophys Res Commun 288: 435-442. (Pubitemid 33022502)
30. Sharff KA, Song WX, Luo X, Tang N, Luo J, Chen J et al. (2009). Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesen-chymal progenitor cells. J Biol Chem 284: 649-659.
31. Song H, Shand JH, Beattie J, Flint DJ, Allan GJ. (2001). The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain. J Mol Endocrinol 26: 229-239. (Pubitemid 32514613)
32. Stolf BS, Carvalho AF, Martins WK, Runza FB, Brun M, Hirata Jr R et al. (2003). Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. Cancer Lett 191: 193-202. (Pubitemid 36255605)
33. Su Y, Luo X, He BC, Wang Y, Chen L, Zuo GW et al. (2009). Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin Exp Metastasis 26: 599-610.
34. Takahashi M, Papavero V, Yuhas J, Kort E, Kanayama HO, Kagawa S et al. (2005). Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol 26: 923-931.
35. Tusher VG, Tibshirani R, Chu G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121. (Pubitemid 32397092)
36. Wang H, Rosen DG, Fuller GN, Zhang W, Liu J. (2006). Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol 19: 1149-1156. (Pubitemid 44268184)
37. Whelan JS. (1997). Osteosarcoma. Eur J Cancer 33: 1611-1618; discussion 1618-9. (Pubitemid 28123483)
38. Xu C, Graf LF, Fazli L, Coleman IM, Mauldin DE, Li D et al. (2007). Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression. Prostate 67: 1621-1629. (Pubitemid 350036948)
39. Yonemoto T, Tatezaki S, Ishii T, Satoh T, Kimura H, Iwai N. (1998). Prognosis of osteosarcoma with pulmonary metastases at initial presentation is not dismal. Clin Orthop 349: 194-199. (Pubitemid 28196564)